Drug Dispensing Service

Talazoparib (Talzenna®)

Program start date: February 1, 2022

Application criteria: (all of the followings)

1. Valid HKID card holder

2. Adult patients of Hong Kong private oncology centre or private hospitals

3. Meet the medical conditions specified by this program

4. Holder of valid Talzenna® purchase receipts or purchase records issued by doctor of private oncology centre or private hospital

5. Patients enrolled in other Talzenna® subsidy or discounted program are not eligible to this program


For program details and the application procedures, please contact SafeMed Dispensary (Tel: 2979- 0380).